Clinical Updatesracial disparitiesphosphorylated tau 217
Plasma Phosphorylated Tau 217 Percentage by Race and Ethnicity in Preclinical Alzheimer Disease: Implications for Screening and Biomarker Utility
By MedXY|Oct 17, 2026
This review synthesizes evidence on racial and ethnic differences in plasma phosphorylated tau 217 (%p-tau217) in preclinical Alzheimer disease, highlighting implications for diagnostic screening and biomarker validity across diverse popula